| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.72(B) |
| Last
Volume: |
548,324 |
Avg
Vol: |
491,730 |
| 52
Week Range: |
$71.24 - $93.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
22,518 |
91,806 |
| Total Sell Value |
$0 |
$0 |
$1,982,727 |
$7,138,305 |
| Total People Sold |
0 |
0 |
4 |
9 |
| Total Sell Transactions |
0 |
0 |
6 |
33 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Basil Michelle L |
EVP and General Counsel |
• • – |
2023-05-12 |
4 |
D |
$88.16 |
$17,985 |
D/D |
(204) |
32,251 |
|
- |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2023-05-02 |
4 |
D |
$81.66 |
$35,114 |
D/D |
(430) |
10,246 |
|
- |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2023-04-14 |
4 |
D |
$84.78 |
$14,921 |
D/D |
(176) |
17,146 |
|
- |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2023-01-23 |
4 |
AS |
$90.00 |
$215,190 |
D/D |
(2,391) |
17,234 |
|
-4% |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2023-01-23 |
4 |
OE |
$56.57 |
$135,259 |
D/D |
2,391 |
19,625 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2022-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,600 |
205,124 |
|
- |
|
| Galvin Roy |
President, Global Plasma & BC |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,382 |
2,382 |
|
- |
|
| Strong Stewart W |
President, Global Hospital |
• • – |
2022-10-24 |
4 |
S |
$80.39 |
$6,029 |
D/D |
(75) |
15,681 |
|
2% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-10-24 |
4 |
S |
$80.39 |
$14,470 |
D/D |
(180) |
32,455 |
|
2% |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2022-09-19 |
4 |
S |
$76.25 |
$16,165 |
D/D |
(212) |
12,697 |
|
-8% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-09-19 |
4 |
AS |
$78.36 |
$897,065 |
D/D |
(11,448) |
32,635 |
|
8% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-09-19 |
4 |
OE |
$38.43 |
$365,743 |
D/D |
8,688 |
44,083 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-09-15 |
4 |
AS |
$77.76 |
$2,632,594 |
D/D |
(33,798) |
35,395 |
|
10% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-09-15 |
4 |
OE |
$38.43 |
$1,200,724 |
D/D |
28,558 |
69,193 |
|
- |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2022-09-06 |
4 |
S |
$73.78 |
$7,452 |
D/D |
(101) |
17,234 |
|
-20% |
|
| Kroll Mark W |
Director |
• • – |
2022-08-15 |
4 |
S |
$73.71 |
$590,859 |
D/D |
(8,016) |
16,231 |
|
-3% |
|
| Burzik Catherine M |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
19,545 |
|
- |
|
| Pomeroy Claire |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
9,746 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
24,247 |
|
- |
|
| Johnson Lloyd Emerson |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
5,807 |
|
- |
|
| Coyle Michael J |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
8,268 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
12,247 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
17,855 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
28,130 |
|
- |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2022-07-05 |
4 |
S |
$66.18 |
$2,780 |
D/D |
(42) |
12,909 |
|
-19% |
|
1310 Records found
|
|
Page 3 of 53 |
|
|
0.45 (0.49%) 
